Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abdel G Babiker

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Current Opinion in HIV and AIDS|April 18, 2009
Considerations in the design of randomized controlled trials evaluating the optimal time to initiate antiretroviral therapy in previously untreated HIV-1-infected patientsAbdel G Babiker, Diana M Gibb
The New England Journal of Medicine|January 28, 2016
Antiretroviral Therapy in Early HIV InfectionJens Lundgren, Abdel G Babiker, James D Neaton
Statistics in Medicine|April 2, 2004
Interval-censored survival time data: confidence intervals for the non-parametric survivor functionRuth L Goodall, David T Dunn, Abdel G Babiker
Statistics in Medicine|February 3, 2004
Parametric randomization-based methods for correcting for treatment changes in the assessment of the causal effect of treatmentA Sarah Walker, Ian R White, Abdel G Babiker
Frontiers in Plant Science|June 1, 2016
Identification of Striga hermonthica-Resistant Upland Rice Varieties in Sudan and Their Resistance PhenotypesHiroaki Samejima, Abdel G Babiker, Ahmed Mustafa, et al.
BMC Medical Research Methodology|September 17, 2016
Combined models for pre- and post-treatment longitudinal biomarker data: an application to CD4 counts in HIV-patientsOliver T Stirrup, Abdel G Babiker, Andrew J Copas
Epidemiology (Cambridge, Mass.)|April 20, 2002
Impact of missing data due to selective dropouts in cohort studies and clinical trialsGiota Touloumi, Stuart J Pocock, Abdel G Babiker, et al.
Statistics in Medicine|November 12, 2015
Fractional Brownian motion and multivariate-t models for longitudinal biomedical data, with application to CD4 counts in HIV-positive patientsOliver T Stirrup, Abdel G Babiker, James R Carpenter, et al.
Contemporary Clinical Trials Communications|January 19, 2026
Type I error control and interim monitoring for co-primary hypotheses involving a subgroup in the Outpatient Treatment with Anti-Coronavirus Immunoglobulin (OTAC) trialJiayi Hu, Abdel G Babiker, Cavan S Reilly, et al.
BMC Medicine|June 18, 2013
When to start antiretroviral therapy: the need for an evidence base during early HIV infectionJens D Lundgren, Abdel G Babiker, Fred M Gordin, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Current Opinion in HIV and AIDS|April 18, 2009
Considerations in the design of randomized controlled trials evaluating the optimal time to initiate antiretroviral therapy in previously untreated HIV-1-infected patientsAbdel G Babiker, Diana M Gibb
The New England Journal of Medicine|January 28, 2016
Antiretroviral Therapy in Early HIV InfectionJens Lundgren, Abdel G Babiker, James D Neaton
Statistics in Medicine|April 2, 2004
Interval-censored survival time data: confidence intervals for the non-parametric survivor functionRuth L Goodall, David T Dunn, Abdel G Babiker
Statistics in Medicine|February 3, 2004
Parametric randomization-based methods for correcting for treatment changes in the assessment of the causal effect of treatmentA Sarah Walker, Ian R White, Abdel G Babiker
Frontiers in Plant Science|June 1, 2016
Identification of Striga hermonthica-Resistant Upland Rice Varieties in Sudan and Their Resistance PhenotypesHiroaki Samejima, Abdel G Babiker, Ahmed Mustafa, et al.
BMC Medical Research Methodology|September 17, 2016
Combined models for pre- and post-treatment longitudinal biomarker data: an application to CD4 counts in HIV-patientsOliver T Stirrup, Abdel G Babiker, Andrew J Copas
Epidemiology (Cambridge, Mass.)|April 20, 2002
Impact of missing data due to selective dropouts in cohort studies and clinical trialsGiota Touloumi, Stuart J Pocock, Abdel G Babiker, et al.
Statistics in Medicine|November 12, 2015
Fractional Brownian motion and multivariate-t models for longitudinal biomedical data, with application to CD4 counts in HIV-positive patientsOliver T Stirrup, Abdel G Babiker, James R Carpenter, et al.
Contemporary Clinical Trials Communications|January 19, 2026
Type I error control and interim monitoring for co-primary hypotheses involving a subgroup in the Outpatient Treatment with Anti-Coronavirus Immunoglobulin (OTAC) trialJiayi Hu, Abdel G Babiker, Cavan S Reilly, et al.
BMC Medicine|June 18, 2013
When to start antiretroviral therapy: the need for an evidence base during early HIV infectionJens D Lundgren, Abdel G Babiker, Fred M Gordin, et al.
Pageof 6